scispace - formally typeset
C

Cornelia Fiessler

Researcher at University of Erlangen-Nuremberg

Publications -  18
Citations -  253

Cornelia Fiessler is an academic researcher from University of Erlangen-Nuremberg. The author has contributed to research in topics: Population & Breast cancer. The author has an hindex of 6, co-authored 14 publications receiving 128 citations. Previous affiliations of Cornelia Fiessler include University of Würzburg.

Papers
More filters
Journal ArticleDOI

Prediction of pathological complete response and prognosis in patients with neoadjuvant treatment for triple-negative breast cancer.

TL;DR: This retrospective study of patients with triple-negative breast cancer adds to the evidence that the treatment effect of platinum may be greatest particularly in G3 tumors, and was a predictor for improved disease-free survival and overall survival in both treatment groups, with and without platinum chemotherapy.
Journal ArticleDOI

Systematic monitoring for detection of atrial fibrillation in patients with acute ischaemic stroke (MonDAFIS): a randomised, open-label, multicentre study.

TL;DR: In this article, the effect of systematic electrocardiogram (ECG) monitoring of patients in hospital on the rate of oral anticoagulant use after 12 months was assessed.
Journal ArticleDOI

Differentiation of malignant liver tumors by software-based perfusion quantification with dynamic contrast-enhanced ultrasound (DCEUS).

TL;DR: DCEUS-values reflect significant differences between malignant liver lesions, especially at peak enhancement and during the washout phases, according to a retrospective study on 148 malignant focal liver lesions assessed prospectively with DCEUS.
Journal ArticleDOI

Association of molecular subtypes with breast cancer risk factors: a case-only analysis.

TL;DR: The study confirmed that age at diagnosis is an important factor influencing the distribution of molecular subtypes and it may be postulated that BMI plays a critical role in the pathogenesis of BC, defining a subgroup that is more likely to develop triple-negative BC or luminal B-like disease and another group in which there is a more postmenopausal distribution pattern.